Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory anti-HER-2 antibody trastuzumab (Herceptin) for the treatment of HER-2-positive advanced metastatic breast cancer, a new era has dawned in the therapy of this malignant disease. Unfortunately, trastuzumab-sensitive cancers invariably develop resistance to the antibody after some time. Recent clinical studies have revealed that these refractory tumors are still responsive to inhibition of the HER receptor family using dual HER-1/-2 inhibitors such as lapatinib (Tykerb/Tyverb). Moreover, a multiplicity of novel, improved irreversibly acting small molecular HER tyrosine kinase inhibitors are in the pipeline of many drug developing companies and are being evaluated in the clinical setting.
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From reader reviews:
Lester Jaworski:
Information is provisions for people to get better life, information presently can get by anyone with everywhere. The information can be a information or any news even a concern. What people must be consider when those information which is inside former life are difficult to be find than now could be taking seriously which one is appropriate to believe or which one the particular resource are convinced. If you find the unstable resource then you buy it as your main information we will see huge disadvantage for you. All of those possibilities will not happen inside you if you take Drugs for HER-2-positive Breast Cancer (Milestones in Drug Therapy) as the daily resource information.
Heather Snyder:
Reading a reserve can be one of a lot of pastime that everyone in the world likes. Do you like reading book so. There are a lot of reasons why people like it. First reading a e-book will give you a lot of new details. When you read a guide you will get new information due to the fact book is one of numerous ways to share the information or maybe their idea. Second, studying a book will make anyone more imaginative. When you examining a book especially fictional book the author will bring you to definitely imagine the story how the characters do it anything. Third, you may share your knowledge to other people. When you read this Drugs for HER-2-positive Breast Cancer (Milestones in Drug Therapy), you can tells your family, friends and soon about yours reserve. Your knowledge can inspire average, make them reading a book.
Tammy Schuler:
Do you like reading a guide? Confuse to looking for your best book? Or your book had been rare? Why so many concern for the book? But virtually any people feel that they enjoy regarding reading. Some people likes examining, not only science book and also novel and Drugs for HER-2-positive Breast Cancer (Milestones in Drug Therapy) or even others sources were given understanding for you. After you know how the fantastic a book, you feel would like to read more and more. Science e-book was created for teacher as well as students especially. Those ebooks are helping them to put their knowledge. In some other case, beside science reserve, any other book likes Drugs for HER-2-positive Breast Cancer (Milestones in Drug Therapy) to make your spare time considerably more colorful. Many types of book like here.
John Yates:
A lot of guide has printed but it takes a different approach. You can get it by online on social media. You can choose the top book for you, science, comedy, novel, or whatever by means of searching from it. It is identified as of book Drugs for HER-2-positive Breast Cancer (Milestones in Drug Therapy). You'll be able to your knowledge by it. Without departing the printed book, it could possibly add your knowledge and make you happier to read. It is most critical that, you must aware about guide. It can bring you from one destination for a other place.
